Crosslife Technologies, founded in 2010 and based in Carlsbad, United States, specializes in the manufacturing of in vitro and in vivo diagnostic substances. The company's core mission is to save lives and improve health through advanced life technologies. Their product offerings include RNA/DNA molecular diagnostics and point-of-care diagnostics, focusing on infectious disease detection. Crosslife Technologies aims to revolutionize healthcare by providing precise and rapid diagnostic solutions.
Notable affiliated individuals and investors have significantly contributed to the company's growth, although specific names are not publicly disclosed. Key achievements include the successful development and deployment of innovative diagnostic tools that enhance disease detection accuracy and speed. The overall impact of Crosslife Technologies is evident in its contribution to healthcare, offering critical diagnostic solutions that improve patient outcomes and streamline medical processes.